1
|
Li W, Zhang Q, Xu Y, Sun H, Wen Y, Xu W, Tong Y, Garg S, Chen Y, Yang Y. Group-based trajectory and predictors of anxiety and depression among Chinese breast cancer patients. Front Public Health 2022; 10:1002341. [PMID: 36299758 PMCID: PMC9589271 DOI: 10.3389/fpubh.2022.1002341] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2022] [Accepted: 09/21/2022] [Indexed: 01/27/2023] Open
Abstract
Background The aim of the current study is to investigate the change in anxiety and depression amongst Chinese breast cancer patients and to identify causal associations between baseline variables and the trajectory of anxiety and depression within this identified group. Methods This is a longitudinal prospective study. Three hundred women with breast cancer were recruited. Patient's depression and anxiety were repeatedly measured by PHQ-9 and GAD-7 at baseline, 6, 12, and 18 months after discharge. The SAS 9.4 PROC Traj procedure was used to examine the group-based trajectory of these recruited patients. Linear mixed models (LMM) were utilized to examine anxiety/depression changes over time, accounting for relevant baseline demographic and clinical factors. Results About 26.3% of the participants reported none or very mild anxiety over time, 60.7% reported stable low-level anxiety, and the remaining 13.0% showed significantly decreasing trend in GAD total scores. Meanwhile, 10.7% of the participants reported none or very mild depressive symptoms over time, 66.0% reported stable PHQ total scores throughout the research period, and 23.3% were classified as the "high level-decreasing group". Patients reported significantly higher anxiety and depression scores in the first three assessments. Participants with no or mild life stress along with a positive personality tended to report lower anxiety and depression scores over time. Conclusion Most of the breast cancer patients reported stable low-level anxiety and depression 18 months after discharge. Early assessment of optimism and stress levels among cancer patients might help identify people at risk of experiencing long-term anxiety and depression.
Collapse
Affiliation(s)
- Wengao Li
- Department of Psychiatry, Guangdong 999 Brain Hospital, Guangzhou, China
| | - Qiongxiao Zhang
- Department of Nursing, Guangzhou First People's Hospital, The Second Affiliated Hospital of South China University of Technology, Guangzhou, China
| | - Yining Xu
- Department of Nursing, Guangzhou First People's Hospital, The Second Affiliated Hospital of South China University of Technology, Guangzhou, China
| | - Hengwen Sun
- Department of Radiotherapy, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangzhou, China
| | - Youlu Wen
- Department of Psychiatry, Guangdong 999 Brain Hospital, Guangzhou, China
| | - Wenjing Xu
- Department of Radiotherapy, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangzhou, China,The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
| | - Yiling Tong
- Department of Radiotherapy, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangzhou, China
| | - Samradhvi Garg
- School of Health in Social Science, University of Edinburgh, Edinburgh, United Kingdom
| | - Yu Chen
- School of Nursing, Southern Medical University, Guangzhou, China,Yu Chen
| | - Yuan Yang
- Guangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangzhou, China,*Correspondence: Yuan Yang
| |
Collapse
|
2
|
Oberoi D, Kwok C, Li Y, Railton C, Horsman S, Reynolds K, Joy AA, King KM, Lupichuk SM, Speca M, Culos-Reed N, Carlson LE, Giese-Davis J. Documenting patients’ and providers’ preferences when proposing a randomized controlled trial: a qualitative exploration. BMC Med Res Methodol 2022; 22:64. [PMID: 35249528 PMCID: PMC8898414 DOI: 10.1186/s12874-022-01549-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2021] [Accepted: 02/14/2022] [Indexed: 11/30/2022] Open
Abstract
Background With advances in cancer diagnosis and treatment, women with early-stage breast cancer (ESBC) are living longer, increasing the number of patients receiving post-treatment follow-up care. Best-practice survivorship models recommend transitioning ESBC patients from oncology-provider (OP) care to community-based care. While developing materials for a future randomized controlled trial (RCT) to test the feasibility of a nurse-led Telephone Survivorship Clinic (TSC) for a smooth transition of ESBC survivors to follow-up care, we explored patients’ and OPs’ reactions to several of our proposed methods. Methods We used a qualitative study design with thematic analysis and a two-pronged approach. We interviewed OPs, seeking feedback on ways to recruit their ESBC patients for the trial, and ESBC patients, seeking input on a questionnaire package assessing outcomes and processes in the trial. Results OPs identified facilitators and barriers and offered suggestions for study design and recruitment process improvement. Facilitators included the novelty and utility of the study and simplicity of methods; barriers included lack of coordination between treating and discharging clinicians, time constraints, language barriers, motivation, and using a paper-based referral letter. OPs suggested using a combination of electronic and paper referral letters and supporting clinicians to help with recruitment. Patient advisors reported satisfaction with the content and length of the assessment package. However, they questioned the relevance of some questions (childhood trauma) while adding questions about trust in physicians and proximity to primary-care providers. Conclusions OPs and patient advisors rated our methods for the proposed trial highly for their simplicity and relevance then suggested changes. These findings document processes that could be effective for cancer-patient recruitment in survivorship clinical trials. Supplementary Information The online version contains supplementary material available at 10.1186/s12874-022-01549-1.
Collapse
|
3
|
Maass S, Boerman L, Verhaak P, Du J, de Bock G, Berendsen A. Long-term psychological distress in breast cancer survivors and their matched controls: A cross-sectional study. Maturitas 2019; 130:6-12. [DOI: 10.1016/j.maturitas.2019.09.003] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2019] [Revised: 07/19/2019] [Accepted: 09/10/2019] [Indexed: 12/19/2022]
|
4
|
Sanchez L, Fernandez N, Calle AP, Ladera V, Casado I, Sahagun AM. Long-term treatment for emotional distress in women with breast cancer. Eur J Oncol Nurs 2019; 42:126-133. [PMID: 31522057 DOI: 10.1016/j.ejon.2019.09.002] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2019] [Revised: 09/04/2019] [Accepted: 09/05/2019] [Indexed: 01/08/2023]
Abstract
PURPOSE Breast cancer patients have many needs, including strategies to cope with the associated distress, during and after cancer treatment. Establishing and implementing adequate social and emotional support for these women, to reduce the detrimental effects of stress resulting from their treatment and disease, is the need of the hour. This study aims to assess how women, diagnosed and treated for breast cancer, combat emotional stress using mechanisms of coping and control and emotional defense, as well as to identify potential groups among them, with different long-term patterns and needs. METHODS 98 patients belonging to a local breast cancer support association (ALMOM), were enrolled in this study. A questionnaire specifically designed for them was administered, and its internal consistency and reliability assessed. A hierarchical clustering was employed to classify the women. The questionnaire focused on four sections, including personal feelings, coping strategies, environmental influences and maladaptive coping. RESULTS An adequate internal reliability was obtained with Cronbach's α near or greater than 0.60. Personal feelings were significant and clearly correlated with coping strategies and maladaptive coping. Three groups of women with different patterns of emotional characteristics and needs were identified: positivist, unsafe, and hopeless women, with different long-term emotional needs to be satisfied. CONCLUSIONS Psychological therapeutic interventions should be maintained in many breast cancer patients over time, even after treatment completion, in order to consolidate adaptive and sustainable responses.
Collapse
Affiliation(s)
- Leticia Sanchez
- Department of Nursing and Physical Therapy, University of Leon, 24071, Leon, Spain.
| | - Nelida Fernandez
- Department of Biomedical Sciences, IBIOMED, University of Leon, 24071, Leon, Spain.
| | - Angela P Calle
- Department of Nursing and Physical Therapy, University of Leon, 24071, Leon, Spain.
| | - Valentina Ladera
- Department of Basic Psychology, Psychobiology and Methodology of Behavioral Sciences, University of Salamanca, 37005, Salamanca, Spain.
| | - Ines Casado
- Department of Nursing and Physical Therapy, University of Leon, 24071, Leon, Spain.
| | - Ana M Sahagun
- Department of Biomedical Sciences, IBIOMED, University of Leon, 24071, Leon, Spain.
| |
Collapse
|
5
|
Klungrit S, Thanasilp S, Jitpanya C. Supportive care needs: An aspect of Thai women with breast cancer undergoing chemotherapy. Eur J Oncol Nurs 2019; 41:82-87. [PMID: 31358262 DOI: 10.1016/j.ejon.2019.05.008] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2018] [Revised: 04/26/2019] [Accepted: 05/31/2019] [Indexed: 10/26/2022]
Abstract
PURPOSE This study was conducted to explore supportive care needs of Thai women with breast cancer undergoing chemotherapy. METHODS Through qualitative interviews, a convenience sample of ten women with invasive and advanced invasive breast cancer who were undergoing chemotherapy were interviewed. Treatment for all women took place at a regional hospital in lower northern Thailand. Ten participants were interviewed, some more than once, for a total of 18 interviews. A qualitative approach with a semi-structured interview guideline was used in data collection. Content analysis was used to analyze the data. RESULTS Four major themes were found: 1) the need for physical comfort and health safety, 2) the need for encouragement, 3) the need for solution of financial problems, and 4) the need for communication and useful information. This qualitative investigation found that supportive care needs of Thai women with breast cancer undergoing chemotherapy are essential for nurses to know in order to provide high quality care. CONCLUSIONS Improvement of supportive care quality for women with breast cancer who are undergoing chemotherapy in Thai culture should include: 1) access to supportive care needs assessment, 2) proactive dissemination of necessary information for better management of their lives, 3) aids to daily living and psychosocial support, and 4) facilitation of easy access to welfare and finance help. Provision of supportive care from both families and health care teams could improve the quality of life and so ease the women's lives for Thai women with breast cancer undergoing chemotherapy.
Collapse
Affiliation(s)
- Supanee Klungrit
- Faculty of Nursing, Chulalongkorn University, Borommaratchachonnani Srisataphat Building, 11th, Floor, Rama I Road, Wangmai Sub-district, Phathumwan District, Bangkok, 10330, Thailand.
| | - Sureeporn Thanasilp
- Faculty of Nursing, Chulalongkorn University, Borommaratchachonnani Srisataphat Building, 11th, Floor, Rama I Road, Wangmai Sub-district, Phathumwan District, Bangkok, 10330, Thailand.
| | - Chanokporn Jitpanya
- Faculty of Nursing, Chulalongkorn University, Borommaratchachonnani Srisataphat Building, 11th, Floor, Rama I Road, Wangmai Sub-district, Phathumwan District, Bangkok, 10330, Thailand.
| |
Collapse
|
6
|
Faye-Schjøll HH, Schou-Bredal I. Pessimism predicts anxiety and depression in breast cancer survivors: A 5-year follow-up study. Psychooncology 2019; 28:1314-1320. [PMID: 30950120 DOI: 10.1002/pon.5084] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2018] [Revised: 02/27/2019] [Accepted: 03/28/2019] [Indexed: 11/09/2022]
Abstract
OBJECTIVE We investigated the prevalence of anxiety and depression at diagnosis and at 1, 3, and 5 years after breast cancer diagnosis. We hypothesized that a low level of optimism (pessimism) at diagnosis could predict change in anxiety and depression 5 years later. METHODS Three hundred sixty-seven women with operable breast cancer were included, and data were collected at all five-time points for 293 of these. Anxiety and depression were measured using the Hospital Anxiety and Depression Scale (HADS). Dispositional optimism/pessimism was measured using the Life Orientation Test-Revised (LOT-R). Frequency analysis was used to determine the prevalence of anxiety and depression. Logistic regression was used to examine dispositional optimism/pessimism as a predictor of change in anxiety and depression 5 years after diagnosis. RESULTS The prevalence rates of anxiety and depression 5 years after diagnosis were 26.3% and 9.6%, respectively. Predictors of change in anxiety 5 years after diagnosis were pessimism (odds ratio [OR] = 0.82; 95% confidence interval [CI]: 0.76-0.89, P < .001); younger age (OR = 0.96; 95% CI: 0.93-0.99, P = .005); and anxiety at diagnosis (OR = 2.41; 95% CI: 1.33-4.37, P = .004). Predictors of change in depression 5 years after diagnosis were pessimism (OR = 0.84; 95% CI: 0.77-0.94, P < .001) and comorbidity (OR = 1.51, 95% CI: 1.10-2.06, P = 0.01). CONCLUSION Anxiety and depression did not decrease after the first postoperative year. Pessimism was a predictor of change in both anxiety and depression 5 years after breast cancer diagnosis.
Collapse
Affiliation(s)
| | - Inger Schou-Bredal
- Department of Cancer, Oslo University Hospital, Oslo, Norway.,Institute for Health and Science, University of Oslo, Oslo, Norway
| |
Collapse
|
7
|
Mathioudakis AG, Salakari M, Pylkkanen L, Saz-Parkinson Z, Bramesfeld A, Deandrea S, Lerda D, Neamtiu L, Pardo-Hernandez H, Solà I, Alonso-Coello P. Systematic review on women's values and preferences concerning breast cancer screening and diagnostic services. Psychooncology 2019; 28:939-947. [PMID: 30812068 PMCID: PMC6594004 DOI: 10.1002/pon.5041] [Citation(s) in RCA: 41] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2018] [Revised: 02/21/2019] [Accepted: 02/25/2019] [Indexed: 11/05/2022]
Abstract
BACKGROUND There is still lack of consensus on the benefit-harm balance of breast cancer screening. In this scenario, women's values and preferences are crucial for developing health-related recommendations. In the context of the European Commission Initiative on Breast Cancer, we conducted a systematic review to inform the European Breast Guidelines. METHODS We searched Medline and included primary studies assessing women's values and preferences regarding breast cancer screening and diagnosis decision making. We used a thematic approach to synthesise relevant data. The quality of evidence was determined with GRADE, including GRADE CERQual for qualitative research. RESULTS We included 22 individual studies. Women were willing to accept the psychological and physical burden of breast cancer screening and a significant risk of overdiagnosis and false-positive mammography findings, in return for the benefit of earlier diagnosis. The anxiety engendered by the delay in getting results of diagnostic tests was highlighted as a significant burden, emphasising the need for rapid and efficient screening services, and clear and efficient communication. The confidence in the findings was low to moderate for screening and moderate for diagnosis, predominantly because of methodological limitations, lack of adequate understanding of the outcomes by participants, and indirectness. CONCLUSIONS Women value more the possibility of an earlier diagnosis over the risks of a false-positive result or overdiagnosis. Concerns remain that women may not understand the concept of overdiagnosis. Women highly value time efficient screening processes and rapid result delivery and will accept some discomfort for the peace of mind screening may provide.
Collapse
Affiliation(s)
- Alexander G Mathioudakis
- Biomedical Research Institute (IIB Sant Pau), Iberoamerican Cochrane Centre, Barcelona, Spain.,Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
| | - Minna Salakari
- Department of Public Health, Faculty of Medicine, University of Turku, Turku, Finland
| | - Liisa Pylkkanen
- Joint Research Centre, European Commission, Ispra, Italy.,Clinico-Pharmacological Unit, Finnish Medicines Agency Fimea, Turku, Finland
| | | | - Anke Bramesfeld
- Joint Research Centre, European Commission, Ispra, Italy.,Institute for Epidemiology Social Medicine and Health System Research, Hanover Medical School, Hannover, Germany
| | - Silvia Deandrea
- Joint Research Centre, European Commission, Ispra, Italy.,Health Protection Agency, Metropolitan city of Milan, Italy
| | - Donata Lerda
- Joint Research Centre, European Commission, Ispra, Italy
| | | | - Hector Pardo-Hernandez
- Biomedical Research Institute (IIB Sant Pau), Iberoamerican Cochrane Centre, Barcelona, Spain.,CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain
| | - Ivan Solà
- Biomedical Research Institute (IIB Sant Pau), Iberoamerican Cochrane Centre, Barcelona, Spain.,CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain
| | - Pablo Alonso-Coello
- Biomedical Research Institute (IIB Sant Pau), Iberoamerican Cochrane Centre, Barcelona, Spain.,CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain
| |
Collapse
|
8
|
Ramalho M, Fontes F, Ruano L, Pereira S, Lunet N. Cognitive impairment in the first year after breast cancer diagnosis: A prospective cohort study. Breast 2017; 32:173-178. [PMID: 28208082 DOI: 10.1016/j.breast.2017.01.018] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2016] [Revised: 01/27/2017] [Accepted: 01/28/2017] [Indexed: 11/16/2022] Open
Abstract
OBJECTIVES The objective of this study was to assess the relation between cancer treatments and incident cognitive impairment in breast cancer patients, taking into account the levels of anxiety before treatment. MATERIALS AND METHODS We conducted a prospective cohort study with 418 newly diagnosed breast cancer patients with no cognitive impairment, defined as values at least 1.5 standard deviations below age- and education-adjusted cut-offs in the Montreal Cognitive Assessment (MoCA), at baseline. The Hospital Anxiety and Depression Scale and MoCA were used for evaluations before treatment and at 1-year after diagnosis. We used Poisson regressions to compute adjusted relative risks (RR) and corresponding 95% confidence intervals (95%CI) to identify predictors of cognitive impairment. RESULTS The median (Percentile 25, Percentile 75) MoCA score before treatment was 24 (21, 26). A total of 8.1% (95%CI: 5.8, 11.2) of the patients presented incident cognitive impairment during the follow-up. There was a statistically significant interaction between anxiety at baseline and the effect of chemotherapy on the incidence of cognitive impairment (P for interaction = 0.028). There was a significantly increased risk of incident cognitive impairment among patients with no anxiety prior to treatment with schemes including doxorubicin and cyclophosphamide (adjusted RR = 4.22, 95%CI: 1.22, 14.65). CONCLUSION There was a statistically significant association between chemotherapy and cognitive impairment, but only among women with no anxiety at baseline.
Collapse
Affiliation(s)
- Mariana Ramalho
- Instituto de Saúde Pública da Universidade do Porto, Rua das Taipas, nº135, 4050-600, Porto, Portugal
| | - Filipa Fontes
- ISPUP - EPIUnit, Universidade do Porto, Rua das Taipas, nº135, 4050-600, Porto, Portugal
| | - Luís Ruano
- ISPUP - EPIUnit, Universidade do Porto, Rua das Taipas, nº135, 4050-600, Porto, Portugal; Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina, Universidade do Porto, Al. Prof. Hernâni Monteiro, 4200-319, Porto, Portugal
| | - Susana Pereira
- ISPUP - EPIUnit, Universidade do Porto, Rua das Taipas, nº135, 4050-600, Porto, Portugal; Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida, 4200-075, Porto, Portugal
| | - Nuno Lunet
- ISPUP - EPIUnit, Universidade do Porto, Rua das Taipas, nº135, 4050-600, Porto, Portugal; Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina, Universidade do Porto, Al. Prof. Hernâni Monteiro, 4200-319, Porto, Portugal.
| |
Collapse
|
9
|
García-Torres F, Alós FJ, Pérez-Dueñas C. Anxiety in common situations of everyday life and depression in women with mastectomies. Psychooncology 2016; 25:1512-1514. [PMID: 26853444 DOI: 10.1002/pon.4074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2015] [Revised: 11/18/2015] [Accepted: 12/17/2015] [Indexed: 11/10/2022]
Affiliation(s)
- Francisco García-Torres
- Department of Psychology, University of Cordoba/IMIBIC Health Research Institute/Reina Sofía University Hospital of Cordoba, Cordoba, Spain
| | - Francisco J Alós
- Department of Psychology, University of Cordoba/IMIBIC Health Research Institute/Reina Sofía University Hospital of Cordoba, Cordoba, Spain
| | - Carolina Pérez-Dueñas
- Department of Psychology, University of Cordoba/IMIBIC Health Research Institute/Reina Sofía University Hospital of Cordoba, Cordoba, Spain
| |
Collapse
|
10
|
Akechi T, Momino K, Miyashita M, Sakamoto N, Yamashita H, Toyama T. Anxiety in disease-free breast cancer patients might be alleviated by provision of psychological support, not of information. Jpn J Clin Oncol 2015; 45:929-33. [DOI: 10.1093/jjco/hyv112] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2015] [Accepted: 06/29/2015] [Indexed: 12/24/2022] Open
|
11
|
The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment: A systematic review. Maturitas 2015; 82:100-8. [PMID: 25998574 DOI: 10.1016/j.maturitas.2015.04.010] [Citation(s) in RCA: 239] [Impact Index Per Article: 26.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2015] [Revised: 04/16/2015] [Accepted: 04/18/2015] [Indexed: 11/23/2022]
Abstract
OBJECTIVES It is unclear whether breast cancer survivors have a higher risk of long-term symptoms of depression or anxiety. The aim of this study was to systematically review the evidence about long-term symptoms of depression and anxiety in breast cancer survivors. STUDY DESIGN Systematic review. MAIN OUTCOME MEASURES PubMed, Embase, Cochrane and PsycINFO were searched for studies with at least 100 survivors ≥1 year after diagnosis, and which used common questionnaires measuring symptoms of depression or anxiety, by two independent reviewers. The quality was assessed with the NIH 'Quality Assessment Tool' checklist. Prevalence of symptoms of depression and anxiety was compared to time since diagnosis, available control groups and a general female population. RESULTS Seventeen articles were included in this review with an average quality score of 57% (range 38-86%). The prevalence of symptoms of depression varied from 9.4% to 66.1% and of anxiety from 17.9% to 33.3%. The results on the depression scale suggested an increase in risk of symptoms of depression for breast cancer survivors at one year after diagnosis, which decreases over the ensuing years. Symptoms of anxiety were not more prevalent among the women with early stage breast cancer. CONCLUSIONS This review suggests a higher prevalence of symptoms of depression among breast cancer survivors than among the general female population, persistent over more than 5 years after diagnosis. Health care providers should be aware of this. There was no indication for an increased prevalence of symptoms of anxiety among breast cancer survivors.
Collapse
|
12
|
García-Torres F, Alós FJ. Anxiety in common situations of everyday life in breast cancer survivors. Psychooncology 2014; 23:953-5. [DOI: 10.1002/pon.3548] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2014] [Revised: 03/20/2014] [Accepted: 03/20/2014] [Indexed: 11/11/2022]
|
13
|
Thompson J, Coleman R, Colwell B, Freeman J, Greenfield D, Holmes K, Mathers N, Reed M. Preparing breast cancer patients for survivorship (PREP) – A pilot study of a patient-centred supportive group visit intervention. Eur J Oncol Nurs 2014; 18:10-6. [DOI: 10.1016/j.ejon.2013.10.004] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2013] [Revised: 09/25/2013] [Accepted: 10/10/2013] [Indexed: 11/29/2022]
|